Table 8 Cost–utility ratios of triple therapy and triple therapy with zeaxanthin
Model | TTZ vs TT | TTZ vs. control cohort | TT vs. control cohort |
|---|---|---|---|
Incremental CUR | Average CUR | Average CUR | |
First-eye model | $7470/QALY | $22,958/QALY | $28,142/QALY |
Second-eye model | $3395/QALY | $15,926/QALY | $23,850/QALY |
Combined-eye model | $5302/QALY | $19,962/QALY | $26.574/QALY |